An outbreak of meningitis in Kent, which led to the deaths of two students, has now reached France, with additional cases confirmed in the UK. The Meningitis B outbreak in Kent has caused concern, prompting panic purchases of vaccinations and students lining up for antibiotics at Kent University. Health Secretary Wes Streeting informed the Commons that the UK Health and Security Agency (UKHSA) was alerted about the initial case on Friday, initiating contact tracing. The UKHSA then informed the University of Kent the next day. Simultaneously, French authorities notified the agency of a case in France linked to the University of Kent.
Two more individuals have been hospitalized due to the disease, bringing the total hospital cases to 15, including the two deceased students. Hospitals started reporting on Saturday that several severely ill young adults exhibited symptoms consistent with meningococcal disease. Precautionary antibiotics were offered to all contacts, with 700 doses administered thus far. Four cases have been confirmed as Meningitis B, a particularly dangerous strain of the illness.
Pharmacies are witnessing a surge in demand for private vaccinations as anxiety over the Kent outbreak persists. Superdrug, a popular pharmacy chain, has experienced a significant increase in bookings for its Meningitis B service compared to the previous week. The store’s website warns of a vaccine shortage, highlighting the seriousness of meningococcal meningitis transmission and its potential complications.
